Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Koninklijke Philips ( (PHG) ) has issued an update.
Royal Philips (Koninklijke Philips N.V.) is a leading Netherlands-based health technology company focused on improving health and well-being through innovation for consumers and healthcare providers. The group is a major player in diagnostic imaging, ultrasound, image-guided therapy, patient monitoring, enterprise informatics and personal health, generating €18 billion in 2025 sales and serving over 100 countries with around 64,300 employees.
Philips shareholders approved all proposals at the company’s Annual General Meeting on May 8, 2026, including the appointment of MedTech veteran John DeFord to the Supervisory Board and the reappointment of three existing Supervisory Board members. They also extended the mandate of President and CEO Roy Jakobs as Chairman of the Board of Management, signaling investor confidence in current leadership and continuity of Philips’ strategic execution as it moves into its next phase of performance and innovation.
The most recent analyst rating on (PHG) stock is a Buy with a $30.30 price target. To see the full list of analyst forecasts on Koninklijke Philips stock, see the PHG Stock Forecast page.
Spark’s Take on PHG Stock
According to Spark, TipRanks’ AI Analyst, PHG is a Neutral.
PHG scores mid-range: improving financial performance and a constructive earnings outlook with reiterated 2026 guidance are the main supports, helped by reasonable valuation. Offsetting these positives are weak technical momentum (below key moving averages with negative MACD) and lingering concerns around earnings/cash-flow consistency and unresolved legal uncertainty.
To see Spark’s full report on PHG stock, click here.
More about Koninklijke Philips
Royal Philips (Koninklijke Philips N.V.) is a leading Netherlands-based health technology company focused on improving health and well-being through innovation for consumers and healthcare providers. The group is a major player in diagnostic imaging, ultrasound, image-guided therapy, patient monitoring, enterprise informatics and personal health, generating €18 billion in 2025 sales and serving over 100 countries with around 64,300 employees.
Philips shareholders approved all proposals at the company’s Annual General Meeting on May 8, 2026, including the appointment of MedTech veteran John DeFord to the Supervisory Board and the reappointment of three existing Supervisory Board members. They also extended the mandate of President and CEO Roy Jakobs as Chairman of the Board of Management, signaling investor confidence in current leadership and continuity of Philips’ strategic execution as it moves into its next phase of performance and innovation.
Average Trading Volume: 1,152,345
Technical Sentiment Signal: Hold
Current Market Cap: $26.19B
For an in-depth examination of PHG stock, go to TipRanks’ Overview page.